(19)
(11) EP 3 152 194 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.10.2019 Bulletin 2019/41

(45) Mention of the grant of the patent:
15.05.2019 Bulletin 2019/20

(21) Application number: 15802538.7

(22) Date of filing: 03.06.2015
(51) International Patent Classification (IPC): 
C07D 235/06(2006.01)
(86) International application number:
PCT/US2015/033962
(87) International publication number:
WO 2015/187818 (10.12.2015 Gazette 2015/49)

(54)

BENZIMIDAZOLE DERIVATIVES

BENZIMIDAZOLDERIVATE

DÉRIVÉS DE BENZIMIDAZOLE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 03.06.2014 US 201462007321 P

(43) Date of publication of application:
12.04.2017 Bulletin 2017/15

(73) Proprietors:
  • Arizona Board of Regents on Behalf of the University of Arizona
    Tucson, AZ 85701 (US)
  • Università degli Studi di Napoli Federico II
    80131 Naples (IT)

(72) Inventors:
  • LI, Hong-yu
    Tucson, AZ 85701 (US)
  • FRETT, Brendan
    Tucson, AZ 85701 (US)
  • SANTORO, Massimo
    I-80131 Naples (IT)
  • CARLOMAGNO, Francesca
    I-80131 Naples (IT)

(74) Representative: Long, Giorgio et al
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)


(56) References cited: : 
EP-B1- 1 904 494
US-A1- 2012 184 561
 US-A1- 2012 135 953
US-A1- 2014 107 172
   
  • VOURLOUMIS, D ET AL.: 'Solid-phase synthesis of benzimidazole libraries biased for RNA targets' TETRAHEDRON LETTERS, [Online] vol. 44, no. 14, 2003, ISSN 0040-4039 pages 2807 - 2811, XP004414453 ISSN: 0040-4039 Retrieved from the Internet: <URL:http://tch.ucsd.edu/pdfs/TetLett_44_28 07_2003.pdf> [retrieved on 2015-07-31]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).